Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	MYH3 ATP7A MYO7A KIF16B ABCF2 MORC2 DNAH1 MYH14 DDX18 ENTPD2 DDX23 DDX20 DHX34 ATP2B2 VCP	3.27e-05	614	142	15	GO:0140657
GeneOntologyMolecularFunction	cobalamin binding	CUBN MMACHC MTR	4.07e-05	10	142	3	GO:0031419
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH3 ATP7A KIF16B ABCF2 MORC2 DDX18 ENTPD2 DDX23 DDX20 DHX34 ATP2B2 VCP	7.58e-05	441	142	12	GO:0016887
GeneOntologyMolecularFunction	RNA polymerase I core binding	RRN3P2 RRN3	2.98e-04	4	142	2	GO:0001042
GeneOntologyMolecularFunction	beta-1 adrenergic receptor binding	MAGI2 DLG4	2.98e-04	4	142	2	GO:0031697
GeneOntologyMolecularFunction	phosphatase binding	CACNA1C WNK1 PTPRT PPP1R3A MAGI2 STRN DLG4 VCP	6.13e-04	264	142	8	GO:0019902
GeneOntologyMolecularFunction	cytoskeletal protein binding	CACNA1C MYH3 MID2 MYO7A SPTBN1 KIF16B MAP1LC3A PTPRT ERMN MAGI2 CYFIP1 NF1 NDRG1 MYH14 DLG4 CORO7 ABLIM2 AGTPBP1	8.10e-04	1099	142	18	GO:0008092
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	KDM4C NR4A3 PTPRT STRN PER2 NFATC1 PDCD11 PRKDC SPEN TBX6	8.14e-04	417	142	10	GO:0061629
GeneOntologyMolecularFunction	pyrophosphatase activity	MYH3 ATP7A ENPP1 KIF16B ABCF2 MORC2 TUBB3 CILP2 DDX18 ENTPD2 DDX23 DDX20 DHX34 ATP2B2 VCP	9.48e-04	839	142	15	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	MYH3 ATP7A ENPP1 KIF16B ABCF2 MORC2 TUBB3 CILP2 DDX18 ENTPD2 DDX23 DDX20 DHX34 ATP2B2 VCP	9.59e-04	840	142	15	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	MYH3 ATP7A ENPP1 KIF16B ABCF2 MORC2 TUBB3 CILP2 DDX18 ENTPD2 DDX23 DDX20 DHX34 ATP2B2 VCP	9.59e-04	840	142	15	GO:0016818
GeneOntologyMolecularFunction	N-acylsphingosine amidohydrolase activity	ASAH2 ASAH2B	1.03e-03	7	142	2	GO:0017040
GeneOntologyBiologicalProcess	neuron development	ATP7A MYO7A ENPP1 FAT3 DPYSL5 RRN3P2 MPDZ NR4A3 SEMA5A RUNX3 WNK1 MAGI2 TUBB3 STRN CYFIP1 NF1 MEGF8 RRN3 TNN LRP1 MTR DLG4 GRIP2 ATP2B2 PLXNB3 AGTPBP1 TBX6	2.19e-06	1463	142	27	GO:0048666
GeneOntologyBiologicalProcess	neuron projection development	ATP7A MYO7A ENPP1 FAT3 DPYSL5 RRN3P2 MPDZ NR4A3 SEMA5A RUNX3 MAGI2 TUBB3 STRN CYFIP1 NF1 MEGF8 RRN3 TNN LRP1 MTR DLG4 ATP2B2 PLXNB3 TBX6	7.21e-06	1285	142	24	GO:0031175
GeneOntologyBiologicalProcess	vascular associated smooth muscle cell migration	ATP7A ENPP1 NR4A3 DOCK5 NF1 LRP1	8.74e-06	70	142	6	GO:1904738
GeneOntologyBiologicalProcess	cell morphogenesis	ATP7A MYO7A ENPP1 FAT3 DPYSL5 NR4A3 SEMA5A CFAP43 ITGA7 RUNX3 ERMN TUBB3 CYFIP1 MEGF8 MYH14 NBEAL2 TNN LRP1 DLG4 PRKDC ATP2B2 PLXNB3	2.25e-05	1194	142	22	GO:0000902
GeneOntologyBiologicalProcess	neuromuscular process	MYH3 MYO7A IGDCC3 NR4A3 MYH14 DLG4 FGF14 ATP2B2 AGTPBP1	2.65e-05	225	142	9	GO:0050905
GeneOntologyBiologicalProcess	cobalamin metabolic process	CUBN MMACHC MTR	3.70e-05	10	142	3	GO:0009235
GeneOntologyBiologicalProcess	regulation of vascular associated smooth muscle cell migration	ATP7A NR4A3 DOCK5 NF1 LRP1	7.93e-05	64	142	5	GO:1904752
GeneOntologyBiologicalProcess	regulation of neuron projection development	FAT3 DPYSL5 RRN3P2 SEMA5A MAGI2 CYFIP1 NF1 MEGF8 RRN3 TNN LRP1 DLG4 PLXNB3 TBX6	8.65e-05	612	142	14	GO:0010975
GeneOntologyBiologicalProcess	positive regulation of vascular associated smooth muscle cell migration	ATP7A NR4A3 DOCK5 LRP1	1.07e-04	36	142	4	GO:1904754
GeneOntologyBiologicalProcess	gamma-aminobutyric acid secretion, neurotransmission	BEST1 NF1	1.41e-04	3	142	2	GO:0061534
GeneOntologyBiologicalProcess	neuromuscular process controlling balance	MYO7A IGDCC3 NR4A3 DLG4 ATP2B2	1.59e-04	74	142	5	GO:0050885
GeneOntologyBiologicalProcess	positive regulation of cell projection organization	ATP7A RRN3P2 SEMA5A MAGI2 CYFIP1 NF1 MEGF8 RRN3 TNN LRP1 DLG4 PLXNB3	1.62e-04	494	142	12	GO:0031346
GeneOntologyBiologicalProcess	regulation of cell development	DPYSL5 HAPLN4 PRXL2A SEMA5A RUNX3 CYFIP1 NF1 PER2 MEGF8 DROSHA LRP1 DLG4 GRIP2 PRKDC SPEN AP3D1 PLXNB3 TBX6 SOS2	1.88e-04	1095	142	19	GO:0060284
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	ATP7A MYO7A FAT3 DPYSL5 NR4A3 SEMA5A RUNX3 TUBB3 CYFIP1 MEGF8 TNN LRP1 DLG4 ATP2B2 PLXNB3	2.05e-04	748	142	15	GO:0048667
GeneOntologyBiologicalProcess	regulation of protein localization to membrane	TCAF2 SORBS2 SPTBN1 WNK1 MAGI2 LRP1 DLG4 GRIP2	2.42e-04	237	142	8	GO:1905475
GeneOntologyBiologicalProcess	Golgi to endosome transport	KIF16B CORO7 DOP1A	2.42e-04	18	142	3	GO:0006895
GeneOntologyBiologicalProcess	cerebellar Purkinje cell differentiation	ATP7A ATP2B2 AGTPBP1	2.42e-04	18	142	3	GO:0021702
GeneOntologyCellularComponent	postsynaptic density	CACNA1C ATP7A SPTBN1 CAST MPDZ DGKZ PTPRT MAGI2 STRN DROSHA LRP1 DLG4 GRIP2 ATP2B2	2.51e-06	451	142	14	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	CACNA1C ATP7A SPTBN1 CAST MPDZ DGKZ PTPRT MAGI2 STRN DROSHA LRP1 DLG4 GRIP2 ATP2B2	4.80e-06	477	142	14	GO:0032279
GeneOntologyCellularComponent	dendrite	CACNA1C SORBS2 ATP7A ENPP1 FAT3 DPYSL5 MPDZ TXNRD2 MAGI2 SLC38A2 TUBB3 STRN CYFIP1 NF1 TNN LRP1 DLG4 GRIP2 ATP2B2	5.75e-06	858	142	19	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CACNA1C SORBS2 ATP7A ENPP1 FAT3 DPYSL5 MPDZ TXNRD2 MAGI2 SLC38A2 TUBB3 STRN CYFIP1 NF1 TNN LRP1 DLG4 GRIP2 ATP2B2	5.95e-06	860	142	19	GO:0097447
GeneOntologyCellularComponent	postsynaptic specialization	CACNA1C ATP7A SPTBN1 CAST MPDZ DGKZ PTPRT MAGI2 STRN DROSHA LRP1 DLG4 GRIP2 ATP2B2	8.76e-06	503	142	14	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	CACNA1C ATP7A SPTBN1 CAST MPDZ DGKZ PTPRT MAGI2 STRN DROSHA LRP1 DLG4 GRIP2 ATP2B2	1.36e-05	523	142	14	GO:0098984
GeneOntologyCellularComponent	glutamatergic synapse	CACNA1C SPTBN1 DPYSL5 MPDZ MAP1LC3A DGKZ PTPRT MAGI2 NF1 DROSHA LRP1 DLG4 GRIP2 ATP2B2 AP3D1 VCP	1.40e-04	817	142	16	GO:0098978
GeneOntologyCellularComponent	somatodendritic compartment	CACNA1C SORBS2 ATP7A ENPP1 FAT3 DPYSL5 MPDZ TXNRD2 ERMN MAGI2 SLC38A2 TUBB3 STRN CYFIP1 NF1 TNN LRP1 DLG4 GRIP2 ATP2B2	2.43e-04	1228	142	20	GO:0036477
GeneOntologyCellularComponent	axon	CACNA1C ATP7A PDGFRA SPTBN1 TXNRD2 ERMN SLC38A2 TUBB3 CYFIP1 NF1 MYH14 TNN LRP1 DLG4 AP3D1 AGTPBP1	3.71e-04	891	142	16	GO:0030424
GeneOntologyCellularComponent	neuronal cell body	CACNA1C SORBS2 ATP7A ENPP1 DPYSL5 TXNRD2 ERMN SLC38A2 TUBB3 STRN CYFIP1 TNN LRP1 GRIP2 ATP2B2	5.68e-04	835	142	15	GO:0043025
GeneOntologyCellularComponent	cell body	CACNA1C SORBS2 ATP7A ENPP1 DPYSL5 TXNRD2 ERMN SLC38A2 TUBB3 STRN CYFIP1 TNN ENTPD2 LRP1 GRIP2 ATP2B2	5.85e-04	929	142	16	GO:0044297
GeneOntologyCellularComponent	actin-based cell projection	ATP7A PDGFRA MYO7A CUBN PKHD1L1 ERMN TUBB3 CYFIP1	6.39e-04	278	142	8	GO:0098858
GeneOntologyCellularComponent	muscle tendon junction	ITGA7 HMCN1	6.75e-04	6	142	2	GO:0005927
GeneOntologyCellularComponent	postsynapse	CACNA1C ATP7A SPTBN1 CAST MPDZ DGKZ PTPRT MAGI2 STRN CYFIP1 DROSHA LRP1 DLG4 GRIP2 ATP2B2 AP3D1	1.53e-03	1018	142	16	GO:0098794
MousePheno	abnormal skeletal muscle morphology	TCAF2 MYH3 ATP7A PDGFRA FAT3 KIF16B CMYA5 ITGA7 MORC2 RUNX3 PPP1R3A NF1 NDRG1 LRP1 AGTPBP1 VCP	6.21e-06	508	119	16	MP:0000759
Domain	-	MID2 PDGFRA MPZL1 HAPLN4 IGDCC3 EBF1 CMYA5 IL18RAP PKHD1L1 PTPRT CILP2 HMCN1 NFATC1 TNN LY9 PLXNB3	3.48e-05	663	139	16	2.60.40.10
Domain	IPT	EBF1 PKHD1L1 NFATC1 PLXNB3	4.51e-05	27	139	4	SM00429
Domain	Ceramidse_alk_C	ASAH2 ASAH2B	5.50e-05	2	139	2	PF17048
Domain	Suf	CSTF3 PDCD11	5.50e-05	2	139	2	PF05843
Domain	NEUT/ALK_ceramidase_C	ASAH2 ASAH2B	5.50e-05	2	139	2	IPR031331
Domain	Suf	CSTF3 PDCD11	5.50e-05	2	139	2	IPR008847
Domain	Ceramidase_alk	ASAH2 ASAH2B	5.50e-05	2	139	2	IPR006823
Domain	Ig-like_fold	MID2 PDGFRA MPZL1 HAPLN4 IGDCC3 EBF1 CMYA5 IL18RAP PKHD1L1 PTPRT CILP2 HMCN1 NFATC1 TNN LY9 PLXNB3	7.34e-05	706	139	16	IPR013783
Domain	TIG	EBF1 PKHD1L1 NFATC1 PLXNB3	7.91e-05	31	139	4	PF01833
Domain	IPT	EBF1 PKHD1L1 NFATC1 PLXNB3	8.99e-05	32	139	4	IPR002909
Domain	TSP_1	THSD4 SEMA5A ADAMTS12 CILP2 HMCN1	1.06e-04	63	139	5	PF00090
Domain	TSP1	THSD4 SEMA5A ADAMTS12 CILP2 HMCN1	1.23e-04	65	139	5	SM00209
Domain	TSP1_rpt	THSD4 SEMA5A ADAMTS12 CILP2 HMCN1	1.23e-04	65	139	5	IPR000884
Domain	TSP1	THSD4 SEMA5A ADAMTS12 CILP2 HMCN1	1.23e-04	65	139	5	PS50092
Domain	Period_circadian-like_C	PER3 PER2	1.64e-04	3	139	2	IPR022728
Domain	Period_C	PER3 PER2	1.64e-04	3	139	2	PF12114
Domain	ARM-type_fold	IPO5 CEP104 VIRMA DOCK5 NF1 NOM1 NBEAL2 PRKDC AP3D1 AGTPBP1	2.29e-04	339	139	10	IPR016024
Domain	EGF_CA	FAT3 CUBN HMCN1 MEGF8 LRP1	4.56e-04	86	139	5	PF07645
Domain	P-loop_NTPase	MYH3 MYO7A KIF16B ABCF2 DNAH1 NDST3 MAGI2 ADSS2 MYH14 UCKL1 DDX18 DDX23 DLG4 DDX20 DHX34 VCP	5.78e-04	848	139	16	IPR027417
Domain	EGF_Ca-bd_CS	FAT3 CUBN HMCN1 MEGF8 LRP1	7.91e-04	97	139	5	IPR018097
Domain	EGF_CA	FAT3 CUBN HMCN1 MEGF8 LRP1	8.68e-04	99	139	5	PS01187
Domain	ASX_HYDROXYL	FAT3 CUBN HMCN1 MEGF8 LRP1	9.08e-04	100	139	5	PS00010
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IPO5 SORBS2 MYO7A SPTBN1 DPYSL5 FKBP9 DGKZ VIRMA ERMN MAGI2 TUBB3 STRN HSPA12A CS CYFIP1 NF1 SUGP2 MYH14 DLG4 CORO7 ABLIM2 ATP2B2 AP3D1 AGTPBP1 VCP HDLBP	1.76e-10	1431	143	26	37142655
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CDC42BPA MYO7A CFAP43 TXNRD2 WNK1 TPCN1 PWWP2B PER2 GAREM2 MEGF8 SUGP2 NFATC1 NBEAL2 UCKL1 ENTPD2 PDCD11 PRKDC SPEN DHX34 AP3D1 IQCE	5.61e-09	1105	143	21	35748872
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	IPO5 SPTBN1 VIRMA CS SUGP2 DROSHA SRSF8 NOM1 DDX18 CSTF3 PDCD11 DDX23 PRKDC CDK11B SPEN DHX34 VCP HDLBP	6.71e-09	807	143	18	22681889
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	THSD4 SEMA5A CUBN ADAMTS12 CILP2 HMCN1 TBX6	2.69e-08	75	143	7	20637190
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	IPO5 SORBS2 KDM4C SPTBN1 CMYA5 MAGI2 TUBB3 ZNF18 CS NDRG1 MYH14 DROSHA DDX18 LRP1 ZNF76 DLG4 PRKDC PLXNB3 AGTPBP1 VCP SOS2	7.38e-08	1285	143	21	35914814
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SORBS2 SPTBN1 CAST SEMA5A MORC2 VIRMA PWWP2B NF1 NDRG1 SUGP2 DDX20 PRKDC CDK11B SPEN AGTPBP1 HDLBP	1.38e-07	774	143	16	15302935
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 SPTBN1 VIRMA NF1 SUGP2 MYH14 DDX18 PDCD11 DDX23 DDX20 PRKDC SPEN VCP HDLBP	5.67e-07	653	143	14	22586326
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SPTBN1 ABCF2 SEC22B TUBB3 CS CYFIP1 NF1 ADSS2 SUGP2 MYH14 DDX18 PDCD11 DDX23 DDX20 PRKDC CORO7 DHX34 AP3D1 VCP HDLBP	7.54e-07	1353	143	20	29467282
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ATP7A CDC42BPA MPZL1 SEC22B PKHD1L1 DOCK5 SLC38A2 SUGP2 NOM1 DDX18 PRKDC SPEN ANO3 AP3D1 IQCE	8.18e-07	777	143	15	35844135
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CDC42BPA SPTBN1 CPM MORC2 VIRMA SUGP2 MYH14 DROSHA SRSF8 NOM1 DDX18 PDCD11 DDX23 DDX20 CDK11B PLOD2 AP3D1 AGTPBP1 VCP HDLBP	9.25e-07	1371	143	20	36244648
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	IPO5 MYH3 CDC42BPA SPTBN1 ABCF2 CMYA5 WNK1 MYH14 DROSHA ABLIM2 AGTPBP1 VCP	1.11e-06	497	143	12	23414517
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	CACNA1C MYO7A SPTBN1 DPYSL5 MORC2 CYFIP1 NBEAL2 HPX DDX23 CDK11B ANO3 AP3D1	1.11e-06	497	143	12	36774506
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	IPO5 MYO7A ABCF2 SEC22B TUBB3 CS CYFIP1 NF1 MYH14 NOM1 NCEH1 PRKDC VCP HDLBP SOS2	1.23e-06	803	143	15	36517590
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CEP104 CACNA1C SPTBN1 SEC22B MAGI2 HSPA12A NF1 DLG4 ABLIM2 ATP2B2	1.90e-06	347	143	10	17114649
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 CACNA1C MYH3 SPTBN1 ABCF2 TRIM43 TRIM43B ADAMTS12 STRN MYH14 TNN ENTPD2 PCDHGB4 DDX23 PRKDC SPEN ATP2B2 AP3D1 ZNF541 DOP1A	2.00e-06	1442	143	20	35575683
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	FBLL1 CDC42BPA VIRMA MYH14 PDCD11 PRKDC ATP2B2 HDLBP	2.05e-06	202	143	8	24639526
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	IPO5 SPTBN1 CAST FKBP9 ABCF2 NUDCD3 CMYA5 WNK1 TUBB3 CS CYFIP1 NDRG1 ADSS2 MYH14 MTR PRKDC PLOD2 AP3D1 VCP HDLBP	2.29e-06	1455	143	20	22863883
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SORBS2 FBLL1 CDC42BPA SPTBN1 DPYSL5 TUBB3 SUGP2 MRPL16 DROSHA DDX18 CSTF3 DDX23 PRKDC CDK11B SPEN AP3D1 VCP	2.44e-06	1082	143	17	38697112
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNA1C BEST1 CDC42BPA MID2 CAST DPYSL5 NUDCD3 DNAH1 DOCK5 PWWP2B NDRG1 SUGP2 NFATC1 MYH14 UCKL1 LRP1 CSTF3 ABLIM2 DOP1A SOS2	3.24e-06	1489	143	20	28611215
Pubmed	Fgf8 genetic labeling reveals the early specification of vestibular hair cell type in mouse utricle.	MYO7A SPTBN1 TUBB3	3.75e-06	8	143	3	33046506
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	IPO5 MPZL1 ABCF2 SEC22B CS NF1 SUGP2 MYH14 DDX18 CSTF3 PDCD11 DDX23 PRKDC SPEN VCP HDLBP	5.28e-06	1024	143	16	24711643
Pubmed	Genome-wide association analysis identifies 13 new risk loci for schizophrenia.	CACNA1C HAPLN4 DNAH1 NEK4 CILP2 PDCD11	6.22e-06	109	143	6	23974872
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	SPTBN1 ABCF2 SEC22B TUBB3 CYFIP1 NCEH1 PRKDC VCP HDLBP	6.25e-06	312	143	9	37120454
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	IPO5 SPTBN1 ABCF2 SEC22B CMYA5 SLC38A2 CS CYFIP1 NF1 ADSS2 MYH14 DDX18 MTR CSTF3 PDCD11 DDX20 PRKDC SPEN HDLBP	6.49e-06	1425	143	19	30948266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SORBS2 VIRMA FEM1B MAGI2 PER2 MEGF8 SUGP2 SPEN PLXNB3 AGTPBP1	7.74e-06	407	143	10	12693553
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	IPO5 ATP7A CDC42BPA SPTBN1 MPDZ ABCF2 CYFIP1 NDRG1 ADSS2 PRKDC AP3D1 VCP HDLBP	7.85e-06	708	143	13	39231216
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	IPO5 SPTBN1 MAP1LC3A ABCF2 MYH14 NOM1 DDX18 PDCD11 DDX23 DDX20 PRKDC CDK11B BCAR3 AP3D1 VCP	9.24e-06	949	143	15	36574265
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	FBLL1 CDC42BPA ABCF2 CYFIP1 SUGP2 MYH14 DROSHA NOM1 DDX18 CSTF3 PDCD11 DDX20 PRKDC VCP	1.14e-05	847	143	14	35850772
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP104 CDC42BPA KIF16B NUDCD3 TPCN1 SLC38A2 NBEAL2 DDHD1 PDCD11 DHX34 IQCE	1.29e-05	529	143	11	14621295
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SORBS2 CDC42BPA PDGFRA SPTBN1 DPYSL5 MPDZ WNK1 VIRMA NEK4 SLC38A2 NF1 NDRG1 MEGF8 DOP1A	1.36e-05	861	143	14	36931259
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TCAF2 MYO7A KIF16B NR4A3 VIRMA NEK4 SLC38A2 CYFIP1 NF1 MEGF8 DDHD1 SPEN	1.40e-05	638	143	12	31182584
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	ATP7A SPTBN1 MPZL1 TUBB3 CYFIP1 NF1	1.49e-05	127	143	6	30442766
Pubmed	Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis.	RRN3P2 RRN3	1.68e-05	2	143	2	12015311
Pubmed	Calpastatin binds to a calmodulin-binding site of cardiac Cav1.2 Ca2+ channels.	CACNA1C CAST	1.68e-05	2	143	2	17950697
Pubmed	Genomic structure and promoter analysis of the mouse neutral ceramidase gene.	ASAH2 ASAH2B	1.68e-05	2	143	2	12435403
Pubmed	Identification of semaphorin 5A interacting protein by applying apriori knowledge and peptide complementarity related to protein evolution and structure.	SEMA5A PLXNB3	1.68e-05	2	143	2	19329067
Pubmed	PMCA2 via PSD-95 controls calcium signaling by α7-containing nicotinic acetylcholine receptors on aspiny interneurons.	DLG4 ATP2B2	1.68e-05	2	143	2	22593058
Pubmed	Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney.	ASAH2 ASAH2B	1.68e-05	2	143	2	11328816
Pubmed	Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.	ASAH2 ASAH2B	1.68e-05	2	143	2	19345744
Pubmed	Lactosylceramide contributes to mitochondrial dysfunction in diabetes.	ASAH2 ASAH2B	1.68e-05	2	143	2	26900161
Pubmed	Vcp Overexpression and Leucine Supplementation Increase Protein Synthesis and Improve Fear Memory and Social Interaction of Nf1 Mutant Mice.	NF1 VCP	1.68e-05	2	143	2	32610136
Pubmed	Possible Association of PER2/PER3 Variable Number Tandem Repeat Polymorphism Variants with Susceptibility and Clinical Characteristics in Pancreatic Cancer.	PER3 PER2	1.68e-05	2	143	2	33393850
Pubmed	A neuroprotective phase precedes striatal degeneration upon nucleolar stress.	RRN3P2 RRN3	1.68e-05	2	143	2	23764776
Pubmed	A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.	ASAH2 ASAH2B	1.68e-05	2	143	2	17334805
Pubmed	Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.	ASAH2 ASAH2B	1.68e-05	2	143	2	26747710
Pubmed	Analysis of fibroblasts from patients with cblC and cblG genetic defects of cobalamin metabolism reveals global dysregulation of alternative splicing.	MMACHC MTR	1.68e-05	2	143	2	32068834
Pubmed	MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.	MORC2 NDRG1	1.68e-05	2	143	2	30407715
Pubmed	Altered intracellular localization and valosin-containing protein (p97 VCP) interaction underlie ATP7A-related distal motor neuropathy.	ATP7A VCP	1.68e-05	2	143	2	22210628
Pubmed	Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells.	PRKDC VCP	1.68e-05	2	143	2	23722536
Pubmed	Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson's disease.	RRN3P2 RRN3	1.68e-05	2	143	2	38745938
Pubmed	Function of the growth-regulated transcription initiation factor TIF-IA in initiation complex formation at the murine ribosomal gene promoter.	RRN3P2 RRN3	1.68e-05	2	143	2	8413268
Pubmed	Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases.	ASAH2 ASAH2B	1.68e-05	2	143	2	10753931
Pubmed	Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.	RRN3P2 RRN3	1.68e-05	2	143	2	30918302
Pubmed	Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.	ASAH2 ASAH2B	1.68e-05	2	143	2	16380386
Pubmed	Variants in the circadian clock genes PER2 and PER3 associate with familial sleep phase disorders.	PER3 PER2	1.68e-05	2	143	2	38695651
Pubmed	Heat shock represses rRNA synthesis by inactivation of TIF-IA and lncRNA-dependent changes in nucleosome positioning.	RRN3P2 RRN3	1.68e-05	2	143	2	27257073
Pubmed	ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth.	RRN3P2 RRN3	1.68e-05	2	143	2	12620228
Pubmed	Distinct functions of Period2 and Period3 in the mouse circadian system revealed by in vitro analysis.	PER3 PER2	1.68e-05	2	143	2	20072700
Pubmed	Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.	ASAH2 ASAH2B	1.68e-05	2	143	2	10652340
Pubmed	Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.	PER3 PER2	1.68e-05	2	143	2	34275001
Pubmed	Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.	ASAH2 ASAH2B	1.68e-05	2	143	2	14557071
Pubmed	Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.	ASAH2 ASAH2B	1.68e-05	2	143	2	35354041
Pubmed	Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.	ASAH2 ASAH2B	1.68e-05	2	143	2	16126722
Pubmed	Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.	ASAH2 ASAH2B	1.68e-05	2	143	2	22940715
Pubmed	Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.	ASAH2 ASAH2B	1.68e-05	2	143	2	24659784
Pubmed	Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.	ASAH2 ASAH2B	1.68e-05	2	143	2	21613224
Pubmed	SEMA5A-PLXNB3 Axis Promotes PDAC Liver Metastasis Outgrowth through Enhancing the Warburg Effect.	SEMA5A PLXNB3	1.68e-05	2	143	2	36741230
Pubmed	Integration of the Deacetylase SIRT1 in the Response to Nucleolar Stress: Metabolic Implications for Neurodegenerative Diseases.	RRN3P2 RRN3	1.68e-05	2	143	2	31110473
Pubmed	DNA binding by the ribosomal DNA transcription factor rrn3 is essential for ribosomal DNA transcription.	RRN3P2 RRN3	1.68e-05	2	143	2	23393135
Pubmed	Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.	MORC2 NDRG1	1.68e-05	2	143	2	34913078
Pubmed	A novel association of two non-synonymous polymorphisms in PER2 and PER3 genes with specific diurnal preference subscales.	PER3 PER2	1.68e-05	2	143	2	23969301
Pubmed	Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons.	RRN3P2 RRN3	1.68e-05	2	143	2	24273493
Pubmed	Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.	ASAH2 ASAH2B	1.68e-05	2	143	2	35151662
Pubmed	Synaptic removal of diacylglycerol by DGKzeta and PSD-95 regulates dendritic spine maintenance.	DGKZ DLG4	1.68e-05	2	143	2	19229292
Pubmed	Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population.	ASAH2 ASAH2B	1.68e-05	2	143	2	37944753
Pubmed	Interaction between methionine synthase isoforms and MMACHC: characterization in cblG-variant, cblG and cblC inherited causes of megaloblastic anaemia.	MMACHC MTR	1.68e-05	2	143	2	23825108
Pubmed	Role of neutral ceramidase in colon cancer.	ASAH2 ASAH2B	1.68e-05	2	143	2	27609772
Pubmed	Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells.	SORBS2 MORC2	1.68e-05	2	143	2	26476214
Pubmed	The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte α-granule biogenesis.	SEC22B NBEAL2	1.68e-05	2	143	2	32384141
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ENPP1 MPDZ MORC2 DENND3 DOCK5 TUBB3 DROSHA NOM1 DDHD1 MTR DHX34 AP3D1	1.69e-05	650	143	12	38777146
Pubmed	Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling.	MPDZ MAGI2 DLG4	1.89e-05	13	143	3	23576434
Pubmed	alphaII-betaV spectrin bridges the plasma membrane and cortical lattice in the lateral wall of the auditory outer hair cells.	MYO7A SPTBN1 TUBB3	1.89e-05	13	143	3	18796539
Pubmed	A Gata3-Mafb transcriptional network directs post-synaptic differentiation in synapses specialized for hearing.	MYO7A TUBB3 DLG4	2.40e-05	14	143	3	24327562
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	SEC22B MORC2 TXNDC12 TUBB3 SPEN VCP DOP1A	2.60e-05	208	143	7	33230847
Pubmed	EBF1 Limits the Numbers of Cochlear Hair and Supporting Cells and Forms the Scala Tympani and Spiral Limbus during Inner Ear Development.	MYO7A EBF1 TUBB3	2.99e-05	15	143	3	38176908
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	SPTBN1 ABCF2 DOCK5 TUBB3 MYH14 CSTF3 PDCD11 PRKDC	3.22e-05	295	143	8	26209609
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NUDCD3 WNK1 STRN CYFIP1 NFATC1 DROSHA MTR DDX20 CDK11B SPEN HDLBP	3.40e-05	588	143	11	38580884
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ENPP1 MPZL1 FKBP9 PRXL2A SEC22B ITGA7 TXNDC12 TPCN1 NEK4 SLC38A2 NF1 MEGF8 LRP1 NCEH1 PLOD2 VCP	3.71e-05	1201	143	16	35696571
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	IPO5 SPTBN1 MPZL1 NR4A3 ABCF2 SEC22B VIRMA TXNDC12 CYFIP1 RRN3 NOM1 LRP1 NCEH1 PRKDC AP3D1 VCP	3.79e-05	1203	143	16	29180619
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	HDX EBF1 RUNX3 TUBB3 CS DDX20 PRKDC SPEN AP3D1	4.09e-05	396	143	9	26687479
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP7A CDC42BPA SPTBN1 KIF16B MPDZ SEC22B NUDCD3 SLC38A2 HSPA12A DDX18 MTR PDCD11 DDX23 PLOD2 AP3D1 AGTPBP1 VCP HDLBP	4.14e-05	1487	143	18	33957083
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	SPTBN1 DPYSL5 TUBB3 HSPA12A CS CYFIP1 DLG4 ATP2B2 VCP	4.69e-05	403	143	9	30562941
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MID2 CAST ABCF2 MORC2 SUGP2 MYH14 RRN3 NOM1 DDX18 SPEN AGTPBP1 HDLBP	4.80e-05	724	143	12	36232890
Pubmed	The molecular circuitry regulating the switch between iron deficiency and overload in mice.	ASAH2 ASAH2B	5.02e-05	3	143	2	16418170
Pubmed	Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects.	PER3 PER2	5.02e-05	3	143	2	19013183
Pubmed	A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light.	PER3 PER2	5.02e-05	3	143	2	9428527
Pubmed	Low-Salt Diet and Circadian Dysfunction Synergize to Induce Angiotensin II-Dependent Hypertension in Mice.	PER3 PER2	5.02e-05	3	143	2	26781276
Pubmed	Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei.	PER3 PER2	5.02e-05	3	143	2	9427249
Pubmed	Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc.	EBF1 NFATC1	5.02e-05	3	143	2	20214815
Pubmed	Association between polymorphisms in period genes and bone density in postmenopausal Korean women.	PER3 PER2	5.02e-05	3	143	2	24678593
Interaction	KCTD13 interactions	IPO5 SORBS2 MYO7A SPTBN1 DPYSL5 FKBP9 DGKZ VIRMA ERMN NDST3 MAGI2 TUBB3 STRN HSPA12A CS CYFIP1 NF1 SUGP2 MYH14 DLG4 CORO7 ABLIM2 ATP2B2 AP3D1 AGTPBP1 VCP HDLBP	1.01e-06	1394	140	27	int:KCTD13
Interaction	KCNA3 interactions	IPO5 ATP7A CDC42BPA SPTBN1 MPDZ ABCF2 SEC22B MORC2 TUBB3 CYFIP1 NDRG1 ADSS2 DLG4 PRKDC SPEN AP3D1 VCP DOP1A HDLBP	9.67e-06	871	140	19	int:KCNA3
Interaction	LAMP1 interactions	ATP7A CDC42BPA SPTBN1 MPZL1 MAP1LC3A SEC22B VIRMA SLC38A2 HSPA12A CYFIP1 NDRG1 MRPL16 MYH14 AP3D1 VCP HDLBP	1.07e-05	644	140	16	int:LAMP1
Interaction	HRAS interactions	CEP104 ATP7A CDC42BPA SPTBN1 MPZL1 DGKZ SEC22B DOCK5 SLC38A2 TUBB3 HSPA12A CYFIP1 NF1 NDRG1 NBEAL2 HDLBP SOS2	1.18e-05	725	140	17	int:HRAS
Interaction	MACROD2 interactions	VIRMA HSPA12A MACROD2	1.79e-05	8	140	3	int:MACROD2
Interaction	TOP3B interactions	IPO5 CDC42BPA MID2 MYO7A CFAP43 TXNRD2 WNK1 TPCN1 PWWP2B PER2 GAREM2 MEGF8 SUGP2 NFATC1 NBEAL2 UCKL1 ENTPD2 PDCD11 DDX20 PRKDC SPEN DHX34 AP3D1 IQCE HDLBP	2.57e-05	1470	140	25	int:TOP3B
Interaction	EZR interactions	IPO5 CDC42BPA CAST FKBP9 ABCF2 TXNRD2 VIRMA SLC38A2 CYFIP1 NDRG1 PER2 DDX18 MACROD2 VCP	3.19e-05	553	140	14	int:EZR
Cytoband	11p14.2	SLC5A12 ANO3	2.00e-04	7	143	2	11p14.2
Cytoband	14q21	DDHD1 SOS2	4.27e-04	10	143	2	14q21
GeneFamily	DEAD-box helicases	DDX18 DDX23 DDX20	1.15e-03	42	89	3	499
GeneFamily	Fibronectin type III domain containing	MID2 IGDCC3 CMYA5 PTPRT TNN	1.16e-03	160	89	5	555
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	MID2 TRIM43 CMYA5 TRIM43B	1.24e-03	95	89	4	59
Coexpression	THUM_SYSTOLIC_HEART_FAILURE_DN	THSD4 CACNA1C SORBS2 CDC42BPA SPTBN1 DOCK5 PER3 PER2 AP3D1	4.07e-06	227	141	9	M18441
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	IPO5 CDC42BPA SPTBN1 SLC38A2 SUGP2 DROSHA PRKDC SPEN AP3D1	8.86e-06	250	141	9	M11318
Coexpression	GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN	IPO5 ABCF2 WNK1 IL18RAP MMACHC PER2 NFATC1 VCP	1.33e-05	200	141	8	M8330
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CACNA1C ENPP1 PRXL2A SEMA5A EBF1 CPM ITGA7 ADAMTS12	1.49e-07	184	143	8	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 CACNA1C DPYSL5 SEMA5A EBF1 ITGA7 PPP1R3A MACROD2	1.62e-07	186	143	8	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNA1C PDGFRA FAT3 ADAMTS12 SLC38A2 HMCN1 FGF14 ANO3	1.69e-07	187	143	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNA1C PDGFRA FAT3 EBF1 ADAMTS12 SLC38A2 HMCN1 FGF14	1.91e-07	190	143	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1C FAT3 EBF1 ADAMTS12 SLC38A2 HMCN1 FGF14 ANO3	2.32e-07	195	143	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C PDGFRA EBF1 ADAMTS12 MAGI2 HMCN1 FGF14 PLOD2	2.51e-07	197	143	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C PDGFRA FAT3 ADAMTS12 SLC38A2 HMCN1 LRP1 FGF14	2.61e-07	198	143	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm\|5w / Sample Type, Dataset, Time_group, and Cell type.	MYH3 MYO7A ASAH2 FKBP9 ITGA7 VIRMA MAGI2 ASAH2B	2.82e-07	200	143	8	0927061536a664b4f7feb9e5b0a8c11ca0d5955c
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 NR4A3 CUBN PKHD1L1 PTPRT DNAH1 ATP2B2	1.27e-06	169	143	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 MYH3 EBF1 ITGA7 ADAMTS12 NDST3 GRIP2	1.73e-06	177	143	7	4553ee8cd9c24db6511b09fe49ed11a89e7cde9e
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	ENPP1 ADAMTS12 CILP2 HMCN1 TNN APCDD1L PLOD2	2.23e-06	184	143	7	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SORBS2 ITGA7 ADAMTS12 NDST3 NDRG1 ENTPD2 PLXNB3	2.49e-06	187	143	7	8e8b147258982b359447add5027318f5b6d51963
ToppCell	LV-03._Atrial_Cardiomyocyte\|LV / Chamber and Cluster_Paper	THSD4 CACNA1C SORBS2 HAPLN4 CMYA5 LY9	2.52e-06	120	143	6	3b77bd0e3630cdd45001cecf5e47660a90ebc92e
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	THSD4 SORBS2 SEMA5A CMYA5 MACROD2 NCEH1 GRIP2	2.67e-06	189	143	7	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	THSD4 SPTBN1 MAP1LC3A SEMA5A DENND3 MYH14 NBEAL2	2.67e-06	189	143	7	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 DPYSL5 CPM ERMN DOCK5 NDRG1 PLXNB3	2.76e-06	190	143	7	396b7225c2430db3dc55a3d0db70239b71987229
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	2.86e-06	191	143	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 MYH3 EBF1 ITGA7 ADAMTS12 NDST3 GRIP2	2.86e-06	191	143	7	9431ffd6b758f756609d9057de2023596e22b5d4
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 PDGFRA CPM ERMN DOCK5 NDRG1 PLXNB3	2.86e-06	191	143	7	2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	2.86e-06	191	143	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDGFRA FAT3 ADAMTS12 HMCN1 FGF14 ANO3	2.86e-06	191	143	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	2.96e-06	192	143	7	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDGFRA FAT3 ADAMTS12 HMCN1 FGF14 ANO3	2.96e-06	192	143	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	2.96e-06	192	143	7	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRA FKBP9 MAP1LC3A CILP2 ENTPD2 LRP1 PLOD2	3.06e-06	193	143	7	eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C PDGFRA FAT3 ADAMTS12 MAGI2 HMCN1 FGF14	3.28e-06	195	143	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 EBF1 ITGA7 ADAMTS12 HMCN1 LRP1 ANO3	3.39e-06	196	143	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	droplet-Heart-HEART-1m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1LC3A SEMA5A ITGA7 CILP2 ENTPD2 LRP1 GRIP2	3.39e-06	196	143	7	1eb14182ef26e6141f510d397b00bf8a12efda3e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 EBF1 ITGA7 ADAMTS12 HMCN1 LRP1 ANO3	3.39e-06	196	143	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDGFRA FAT3 EBF1 ADAMTS12 HMCN1 FGF14	3.39e-06	196	143	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MPZL1 EBF1 ADAMTS12 NFATC1 ABLIM2 ANO3	3.51e-06	197	143	7	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	3.51e-06	197	143	7	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 MPZL1 EBF1 ADAMTS12 NFATC1 ABLIM2 ANO3	3.51e-06	197	143	7	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 PDGFRA ENPP1 EBF1 ADAMTS12 LRP1 ANO3	3.51e-06	197	143	7	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C PDGFRA FAT3 EBF1 ADAMTS12 HMCN1 FGF14	3.63e-06	198	143	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	facs-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 CDC42BPA ENPP1 MPZL1 CILP2 NFATC1 PLOD2	3.63e-06	198	143	7	71e847e8c24744d6df4a960348ad2ecf310373b4
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT3 EBF1 ADAMTS12 HMCN1 LRP1 FGF14	3.87e-06	200	143	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EBF1 ITGA7 MORC2 ADAMTS12 DROSHA NYNRIN LRP1	3.87e-06	200	143	7	5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT3 EBF1 ADAMTS12 HMCN1 LRP1 FGF14	3.87e-06	200	143	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT3 EBF1 ADAMTS12 HMCN1 LRP1 FGF14	3.87e-06	200	143	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C SEMA5A EBF1 CPM ITGA7 ADAMTS12 GRIP2	3.87e-06	200	143	7	9d3ae9ea47b1017adb63aa02d10e98193d478458
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C FAT3 EBF1 ADAMTS12 HMCN1 LRP1 FGF14	3.87e-06	200	143	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	THSD4 CACNA1C CDC42BPA SPTBN1 MPDZ EBF1 MAGI2	3.87e-06	200	143	7	7136936d05ab344a560cf159684c881063b5430d
ToppCell	LV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	THSD4 CACNA1C SORBS2 HAPLN4 CMYA5 LY9	4.00e-06	130	143	6	a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A WNK1 PKHD1L1 CILP2 NDRG1 ABLIM2	1.51e-05	164	143	6	4cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A WNK1 PKHD1L1 CILP2 NDRG1 ABLIM2	1.51e-05	164	143	6	7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PDGFRA ASAH2 FAT3 CILP2 ANO3 ASAH2B	1.51e-05	164	143	6	583dda853cee9491dbdcb228c23d8deadc20eb08
ToppCell	PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A WNK1 PKHD1L1 CILP2 NDRG1 ABLIM2	1.51e-05	164	143	6	5e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCell	PND10-Endothelial-Endothelial_lymphatic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A WNK1 PKHD1L1 CILP2 NDRG1 ABLIM2	1.51e-05	164	143	6	f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP43 CUBN IL18RAP PTPRT DNAH1 FGF14	1.79e-05	169	143	6	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD4 SORBS2 ENPP1 FAT3 MAGI2 PLOD2	1.79e-05	169	143	6	58e22f9119240664515fe91ca53812611a8f17d6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 EBF1 ADAMTS12 SLC38A2 ABLIM2 ANO3	1.85e-05	170	143	6	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 EBF1 ADAMTS12 SLC38A2 ABLIM2 ANO3	1.85e-05	170	143	6	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	CACNA1C SEMA5A EBF1 ITGA7 SLC38A2 ABLIM2	1.92e-05	171	143	6	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C KDM4C TRIM43 PTPRT SLC38A2 DOP1A	2.11e-05	174	143	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	ENPP1 FKBP9 EBF1 PER3 LRP1 PLOD2	2.26e-05	176	143	6	ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HMCN1 NFATC1 LRP1 FGF14 ANO3	2.26e-05	176	143	6	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 HMCN1 NFATC1 LRP1 FGF14 ANO3	2.26e-05	176	143	6	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C SEMA5A EBF1 ITGA7 FGF14 SLC5A12	2.40e-05	178	143	6	066dbc4cc2083c549d98122ed44707127f34d582
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	CACNA1C SEMA5A EBF1 CPM DENND3 ADAMTS12	2.64e-05	181	143	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C ENPP1 SEMA5A EBF1 ITGA7 ADAMTS12	2.64e-05	181	143	6	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1C SEMA5A EBF1 CPM DENND3 ADAMTS12	2.81e-05	183	143	6	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	COVID-19-Epithelial_cells-ECM-high_epithelial\|COVID-19 / group, cell type (main and fine annotations)	THSD4 CACNA1C SPTBN1 TUBB3 MYH14 MACROD2	2.81e-05	183	143	6	dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 MYH3 ITGA7 ADAMTS12 NDST3 GRIP2	2.81e-05	183	143	6	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	CDC42BPA SEMA5A EBF1 CPM DENND3 ADAMTS12	2.81e-05	183	143	6	273db6a3b00a93ca852498471187b642b5368185
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CPM ERMN DOCK5 NDRG1 PLXNB3	2.81e-05	183	143	6	93213124e55d1b673dd345188caf8b5bd31d99fe
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO7A HSPA12A DDHD1 LRP1 NCEH1 BCAR3	2.90e-05	184	143	6	15ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO7A HSPA12A DDHD1 LRP1 NCEH1 BCAR3	2.90e-05	184	143	6	bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDGFRA ADAMTS12 CILP2 HMCN1 APCDD1L PLOD2	2.98e-05	185	143	6	87c416d14ca6255bee39b16e7571553e36ee3069
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C MAP1LC3A SEMA5A EBF1 FGF14 ABLIM2	2.98e-05	185	143	6	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SPTBN1 EBF1 PKHD1L1 DOCK5 ABLIM2	2.98e-05	185	143	6	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	ILEUM-inflamed-(7)_Lymphatics\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SPTBN1 PRXL2A MPDZ CMYA5 NDST3 DOCK5	2.98e-05	185	143	6	d711dd2e91cfee723dae1ccb2b910b8cf3becc3b
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C SEMA5A EBF1 ITGA7 FGF14 ABLIM2	2.98e-05	185	143	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	CACNA1C SEMA5A EBF1 CPM DENND3 ADAMTS12	2.98e-05	185	143	6	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	THSD4 CACNA1C SORBS2 CMYA5 NCEH1 GRIP2	2.98e-05	185	143	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	THSD4 SPTBN1 EBF1 PKHD1L1 DOCK5 ABLIM2	2.98e-05	185	143	6	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDGFRA NR4A3 PTPRT CILP2 TNN FGF14	3.08e-05	186	143	6	4e983de6d2515082f9e555f4f949cec84281c140
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CACNA1C FAT3 NR4A3 SEMA5A EBF1 ADAMTS12	3.08e-05	186	143	6	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CPM ERMN DOCK5 NDRG1 PLXNB3	3.08e-05	186	143	6	d57c40b3fe5cfc87e771df76533d9a3e94678b04
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CPM ERMN DOCK5 NDRG1 PLXNB3	3.08e-05	186	143	6	90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST1 CPM ERMN DOCK5 NDRG1 PLXNB3	3.08e-05	186	143	6	bd8a9753df219084e19e7f94447856e86608325c
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA EBF1 CPM TNN LRP1 ANO3	3.17e-05	187	143	6	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA5A CPM DENND3 MYH14 NBEAL2 MACROD2	3.17e-05	187	143	6	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C SEMA5A EBF1 ITGA7 MAGI2 PLOD2	3.17e-05	187	143	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD4 CACNA1C NR4A3 EBF1 ADAMTS12 ANO3	3.17e-05	187	143	6	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA EBF1 CPM TNN LRP1 ANO3	3.17e-05	187	143	6	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA EBF1 CPM TNN LRP1 ANO3	3.17e-05	187	143	6	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	CACNA1C CDC42BPA EBF1 CPM DENND3 ADAMTS12	3.17e-05	187	143	6	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	THSD4 CAST SEMA5A EBF1 ITGA7 BCAR3	3.17e-05	187	143	6	1aebf6fab40b96f2f5feb77a302bb805838fccf3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	THSD4 SPTBN1 SEMA5A DENND3 MYH14 NBEAL2	3.17e-05	187	143	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	CACNA1C PDGFRA FAT3 ADAMTS12 HMCN1 FGF14	3.17e-05	187	143	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	THSD4 SORBS2 SEMA5A CMYA5 NCEH1 GRIP2	3.17e-05	187	143	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C MAP1LC3A SEMA5A EBF1 FGF14 ABLIM2	3.17e-05	187	143	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	THSD4 CACNA1C SORBS2 CMYA5 ITGA7 GRIP2	3.27e-05	188	143	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPM DENND3 DOCK5 MYH14 NBEAL2 MACROD2	3.27e-05	188	143	6	eea652bab161f19148a883e7e3fe2523b36b3cea
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; HL60; HG-U133A	CDC42BPA ITGA7 WNK1 ADAMTS12 DOCK5 NF1 SUGP2 PDCD11 LY9 DHX34 AP3D1	4.48e-08	198	141	11	1740_UP
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	IPO5 CEP104 SPTBN1 ITGA7 RUNX3 CSTF3 PDCD11 DHX34 IQCE	3.49e-06	194	141	9	1166_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	KDM4C SPTBN1 ABCF2 RUNX3 WNK1 NF1 NBEAL2 ZNF76 SOS2	3.80e-06	196	141	9	5765_DN
Drug	Ronidazole [7681-76-7]; Up 200; 20uM; HL60; HT_HG-U133A	THSD4 SPTBN1 PKDREJ ADAMTS12 PER3 NYNRIN BCAR3 ATP2B2 DOP1A	4.30e-06	199	141	9	6134_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	CDC42BPA WNK1 MAGI2 HSPA12A NF1 MEGF8 DHX34 TBX6 SOS2	4.30e-06	199	141	9	4775_UP
Drug	Dubinidine [22964-77-8]; Down 200; 14.6uM; PC3; HT_HG-U133A	KDM4C SPTBN1 ABCF2 NUDCD3 FEM1B SUGP2 NBEAL2 ZNF76 DHX34	4.48e-06	200	141	9	5774_DN
Drug	perfluoromethylcyclohexane	WNK1 CS NDRG1	1.27e-05	8	141	3	CID000009637
Drug	Hydroxocobalamin	CUBN MMACHC MTR	1.90e-05	9	141	3	DB00200
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; HL60; HT_HG-U133A	BEST1 CDC42BPA PDGFRA SPTBN1 NR4A3 DOCK5 LRP1 IQCE	2.14e-05	186	141	8	2202_UP
Drug	PTC124	ITGA7 NFATC1 HPX VCP	2.21e-05	27	141	4	CID011219835
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A	CEP104 MID2 SPTBN1 DOCK5 FEM1B NF1 DHX34 SOS2	2.69e-05	192	141	8	7155_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	SPTBN1 ABCF2 WNK1 PTPRT NF1 NYNRIN LY9 ATP2B2	2.69e-05	192	141	8	6512_UP
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	NF1 MEGF8 NFATC1 LRP1 ZNF76 LY9 DOP1A TBX6	2.90e-05	194	141	8	6368_UP
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; HL60; HT_HG-U133A	MPZL1 NR4A3 NFATC1 MYH14 ZNF76 DLG4 DHX34 SOS2	2.90e-05	194	141	8	1868_UP
Drug	Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A	THSD4 NUDCD3 ITGA7 PKDREJ NF1 MEGF8 MYH14 HPX	3.00e-05	195	141	8	6074_UP
Drug	estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	CACNA1C NR4A3 MYH14 NYNRIN HPX ZNF76 LY9 SOS2	3.23e-05	197	141	8	5905_DN
Drug	1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	MYO7A ABCF2 CUBN DENND3 PTPRT STRN LRP1 AP3D1	3.23e-05	197	141	8	22_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	ITGA7 MMACHC FEM1B MEGF8 MYH14 LY9 IQCE TBX6	3.23e-05	197	141	8	2484_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A	CDC42BPA SPTBN1 NUDCD3 ADAMTS12 DOCK5 NF1 IMPG2 SOS2	3.23e-05	197	141	8	2249_UP
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	CDC42BPA KDM4C ABCF2 FEM1B NF1 MYH14 IQCE SOS2	3.23e-05	197	141	8	5482_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	PDGFRA ABCF2 WNK1 TPCN1 FEM1B STRN NF1 SOS2	3.35e-05	198	141	8	5799_DN
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A	CDC42BPA KDM4C SPTBN1 SEMA5A RUNX3 FEM1B STRN DHX34	3.47e-05	199	141	8	5787_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	IPO5 CEP104 CDC42BPA CAST RUNX3 ZNF76 LY9 PLOD2	3.47e-05	199	141	8	2556_DN
Drug	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	SPTBN1 DPYSL5 SEMA5A NF1 DLG4 NCEH1 FGF14 ATP2B2	5.25e-05	211	141	8	ctd:C009618
Disease	Malignant neoplasm of breast	KIF16B HAPLN4 CUBN WNK1 PKDREJ PPP1R3A TUBB3 NF1 NDRG1 PER3 PER2 DDX18 MTR BCAR3 SPEN ZNF541 DOP1A HDLBP	3.53e-06	1074	140	18	C0006142
Disease	vitelliform macular dystrophy (implicated_via_orthology)	BEST1 IMPG2	2.24e-05	2	140	2	DOID:0050661 (implicated_via_orthology)
Disease	Advanced Sleep-Phase Syndrome, Familial	PER3 PER2	6.68e-05	3	140	2	C1858496
Disease	Schizophrenia	IPO5 CACNA1C MPZL1 CMYA5 ADAMTS12 NDST3 MAGI2 SLC38A2 HSPA12A CYFIP1 ADSS2 LRP1 MTR DLG4	8.31e-05	883	140	14	C0036341
Disease	advanced sleep phase syndrome (is_implicated_in)	PER3 PER2	1.33e-04	4	140	2	DOID:0050628 (is_implicated_in)
Disease	Vitelliform Macular Dystrophy	BEST1 IMPG2	1.33e-04	4	140	2	C0339510
Disease	Juvenile-Onset Vitelliform Macular Dystrophy	BEST1 IMPG2	1.33e-04	4	140	2	C2745945
Disease	Adult-Onset Vitelliform Macular Dystrophy	BEST1 IMPG2	1.33e-04	4	140	2	C1842914
Disease	medulloblastoma (is_marker_for)	PDGFRA KDM4C	2.21e-04	5	140	2	DOID:0050902 (is_marker_for)
Disease	3-methyl-2-oxovalerate measurement	SORBS2 MACROD2	2.21e-04	5	140	2	EFO_0021021
Disease	vitelliform macular dystrophy (is_implicated_in)	BEST1 IMPG2	2.21e-04	5	140	2	DOID:0050661 (is_implicated_in)
Disease	total blood protein measurement	CAST EBF1 RUNX3 DNAH1 NYNRIN FGF14 ASAH2B IMPG2 HDLBP	3.05e-04	449	140	9	EFO_0004536
Disease	acylcarnitine measurement	PTPRT PPP1R3A NFATC1 MACROD2 DLG4	3.58e-04	127	140	5	EFO_0005059
Disease	cardiomyopathy (implicated_via_orthology)	MYH3 ASAH2 ITGA7 LRP1	3.69e-04	71	140	4	DOID:0050700 (implicated_via_orthology)
Disease	Glioblastoma	PDGFRA RUNX3 NF1 NDRG1	5.54e-04	79	140	4	C0017636
Disease	Alcohol withdrawal syndrome	KDM4C MPDZ	6.14e-04	8	140	2	C0236663
Disease	nitric oxide exhalation measurement	CACNA1C PTPRT ANO3	7.81e-04	38	140	3	EFO_0005536
Disease	infection	MACROD2 ZNF541	7.87e-04	9	140	2	EFO_0000544
Disease	post operative nausea and vomiting	FAT3 FGF14	7.87e-04	9	140	2	EFO_0004888
Disease	alcohol consumption measurement	CACNA1C KDM4C SPTBN1 DPYSL5 NDST3 MAGI2 NF1 MACROD2 CSTF3 FGF14 BCAR3 ABLIM2 IQCE IMPG2 TBX6	8.47e-04	1242	140	15	EFO_0007878
Disease	comparative body size at age 10, self-reported	KDM4C DGKZ EBF1 WNK1 MAGI2 NF1 NFATC1 MACROD2	9.19e-04	420	140	8	EFO_0009819
Disease	Disorders of Intracellular Cobalamin Metabolism	MMACHC MTR	9.81e-04	10	140	2	cv:CN043592
Disease	autistic disorder (is_implicated_in)	KDM4C NF1 MTR	1.05e-03	42	140	3	DOID:12849 (is_implicated_in)
Disease	triacylglycerol 56:2 measurement	MACROD2 SLC5A12	1.20e-03	11	140	2	EFO_0010429
Disease	interleukin-22 receptor subunit alpha-2 measurement	SEC22B RUNX3	1.20e-03	11	140	2	EFO_0020500
Disease	melanoma	PDGFRA MYO7A KDM4C CUBN NF1 NDRG1	1.22e-03	248	140	6	C0025202
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KDM4C PTPRT SPEN	1.28e-03	45	140	3	DOID:3748 (is_implicated_in)
Disease	aortic measurement	THSD4 CAST MORC2 HMCN1 LRP1 AP3D1	1.30e-03	251	140	6	EFO_0020865
Disease	homocysteine measurement	CUBN MMACHC MTR	1.37e-03	46	140	3	EFO_0004578
Disease	serum gamma-glutamyl transferase measurement	THSD4 SORBS2 CDC42BPA HDX EBF1 CPM STRN NF1 NBEAL2 MACROD2 ASAH2B HDLBP	1.41e-03	914	140	12	EFO_0004532
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	PDGFRA LRP1	1.43e-03	12	140	2	DOID:3827 (implicated_via_orthology)
Disease	Dental enamel hypoplasia	MYH14 MACROD2	1.43e-03	12	140	2	EFO_1001304
Disease	Celiac Disease	ASAH2 RUNX3 MAGI2	1.45e-03	47	140	3	C0007570
Disease	handedness	MYH3 TUBB3 NDRG1 PCDHGB4	1.66e-03	106	140	4	EFO_0009902
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MORC2 WNK1	1.68e-03	13	140	2	C0270914
Disease	Glioblastoma Multiforme	PDGFRA RUNX3 NF1 NDRG1	1.96e-03	111	140	4	C1621958
Disease	Bipolar Disorder	CACNA1C NEK4 NDST3 MAGI2 PER3 PER2 MTR DLG4	2.05e-03	477	140	8	C0005586
Disease	Drug habituation	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0013170
Disease	Drug abuse	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0013146
Disease	Prescription Drug Abuse	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C4316881
Disease	Substance-Related Disorders	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0236969
Disease	Drug Use Disorders	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0013222
Disease	Drug Dependence	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C1510472
Disease	Substance Dependence	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0038580
Disease	Substance Use Disorders	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	THSD4 HSPA12A MACROD2 BCAR3	2.23e-03	115	140	4	C0029231
Disease	Lymphoma, Follicular, Grade 2	EBF1 MTR	2.25e-03	15	140	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	EBF1 MTR	2.25e-03	15	140	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	EBF1 MTR	2.25e-03	15	140	2	C1956130
Disease	Yu-Zhi constitution type	RRN3P2 MACROD2	2.25e-03	15	140	2	EFO_0007638
Disease	Lymphoma, Large-Cell, Follicular	EBF1 MTR	2.25e-03	15	140	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	EBF1 MTR	2.25e-03	15	140	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	EBF1 MTR	2.25e-03	15	140	2	C0079758
Disease	osteoarthritis (implicated_via_orthology)	ATP7A ENPP1	2.25e-03	15	140	2	DOID:8398 (implicated_via_orthology)
Disease	Substance abuse problem	THSD4 HSPA12A MACROD2 BCAR3	2.30e-03	116	140	4	C0740858
Disease	optic cup area measurement	CDC42BPA FAT3 HSPA12A	2.41e-03	56	140	3	EFO_0006940
Disease	cortical thickness	THSD4 FAT3 SPTBN1 DPYSL5 EBF1 CPM DENND3 TUBB3 STRN MACROD2 PCDHGB4 LRP1 SOS2	2.52e-03	1113	140	13	EFO_0004840
Disease	creatinine measurement	DPYSL5 PRXL2A CUBN DYDC2 PPP1R3A CILP2 NDRG1 NFATC1 PCDHGB4 BCAR3 ASAH2B SOS2	2.85e-03	995	140	12	EFO_0004518
Disease	SLAM family member 7 measurement	RUNX3 LY9	2.90e-03	17	140	2	EFO_0008287
Disease	Moyamoya Disease	ATP7A NF1	2.90e-03	17	140	2	C0026654
Disease	hip bone mineral density	IPO5 HSPA12A MACROD2 FGF14	3.11e-03	126	140	4	EFO_0007702
Disease	lysophosphatidylcholine measurement	BEST1 RRN3 FGF14	3.22e-03	62	140	3	EFO_0010224
Disease	esterified cholesterol measurement	BEST1 HAPLN4 NYNRIN DLG4	3.29e-03	128	140	4	EFO_0008589
Disease	platelet component distribution width	CACNA1C KIF16B CUBN WNK1 DOCK5 CYFIP1 TNN NYNRIN DDHD1 IQCE	3.30e-03	755	140	10	EFO_0007984
Disease	serum IgG glycosylation measurement	CAST ABCF2 CPM RUNX3 PTPRT DHX34 C13orf42 SOS2	3.59e-03	523	140	8	EFO_0005193
Disease	Cannabis use, age at onset	CAST PCDHGB4	3.63e-03	19	140	2	EFO_0004847, EFO_0007585
Disease	urate measurement	DPYSL5 PRXL2A CUBN DYDC2 PTPRT DNAH1 UCKL1 LRP1 ASAH2B IQCE SOS2	3.68e-03	895	140	11	EFO_0004531
Disease	aspartate aminotransferase measurement	MYO7A KIF16B CAST CUBN IL18RAP ADAMTS12 HSPA12A CILP2 NF1 PCDHGB4 SOS2	3.97e-03	904	140	11	EFO_0004736
Disease	taurocholate measurement	CDC42BPA DOCK5	4.02e-03	20	140	2	EFO_0010538
Disease	Lymphoma, Follicular	EBF1 MTR	4.02e-03	20	140	2	C0024301
Disease	bipolar I disorder	CACNA1C CUBN MACROD2 ATP2B2	4.64e-03	141	140	4	EFO_0009963
Disease	cortical surface area measurement, neuroimaging measurement	THSD4 FAT3 SPTBN1 TUBB3 STRN	4.64e-03	227	140	5	EFO_0004346, EFO_0010736

Protein segments in the cluster

Peptide	Gene	Start	Entry
IGKREVPIPEHIDIY	ABCF2	131	Q9UG63
LLPEEEHTGIYILKP	CFAP43	616	Q8NDM7
RDPHLLDPTVEYVKF	BCAR3	106	O75815
PAKPEYRVGEVAEVI	ASAH2B	46	P0C7U1
PLGIRLPHVEYELFK	APCDD1L	401	Q8NCL9
ERHPIYLPKAVEGAF	C13orf42	241	A0A1B0GVH6
PGGVHRKALETYEII	DOP1A	76	Q5JWR5
HVPDTGVKDNIYRKP	ABLIM2	421	Q6H8Q1
AKAYPGHELDLVVPV	BEST1	261	O76090
DGLKHEYFRETPLPI	CDK11B	716	P21127
LEKPVEIIRHYTGPG	DDX20	606	Q9UHI6
VLLYTPGHLDPAEKV	DENND3	896	A2RUS2
GPTLHDPDLYIEIVK	AGTPBP1	621	Q9UPW5
VGDVHYKEIPDPSSI	ATP2B2	516	Q01814
IKGLPEYHVVGPVRV	ADAMTS12	46	P58397
IAYLIPDVPKGLHDR	ANO3	931	Q9BYT9
KRYQDTPGVEHIPVV	AP3D1	691	O14617
IKYDPEIIGPRDIIH	ATP7A	606	Q04656
NLRVREHPKEGPYVE	KIF16B	171	Q96L93
YHIEIAPGKGDLPVL	NDST3	106	O95803
NGHVPGTPVYREKED	IQCE	131	Q6IPM2
VPHAAEPGYLVTKVV	PCDHGB4	576	Q9UN71
EVKHFVVEVRAYPPP	PDGFRA	331	P16234
ESKYAPLHLVPLIER	CYFIP1	1051	Q7L576
GDPLEDIRKSYPHII	IL18RAP	91	O95256
KIEPVGIQRSYKPEH	HDX	221	Q7Z353
GYVLHIRKAADPPEL	IGDCC3	456	Q8IVU1
TTRPHKEGEVPGVDY	MAGI2	141	Q86UL8
YTDLEVRVPVPKHVV	NUDCD3	196	Q8IVD9
VAKVRPSDPIEYLAH	DYDC2	21	Q96IM9
RYVILKSEPVHPFGL	LRP1	2411	Q07954
PAKPEYRVGEVAEVI	ASAH2	661	Q9NR71
LEKEVLPPIHAYGNR	FEM1B	291	Q9UK73
TAIVPIGYHVPRKAV	CORO7	336	P57737
DVPKERHAGTPLYLG	ENTPD2	106	Q9Y5L3
RDHAVVVGVYRPLPK	FBLL1	316	A6NHQ2
KRHEVPPHVYAVTEG	MYH14	166	Q7Z406
RVHSGYEAPRIPPEK	PER2	316	O15055
EKIHSGYEAPRIPVN	PER3	256	P56645
PYRLKPGHVLDVEGE	PLXNB3	1161	Q9ULL4
PTLNPVIYGVRTKHI	OR52E6	286	Q96RD3
RFLPSHPIVGKVDVT	NEK4	566	P51957
PEEPLKRSVVYIHGG	NCEH1	101	Q6PIU2
TPKGNRPVILTYHDI	NDRG1	51	Q92597
EKGAVVPPVHDIYRA	CSTF3	696	Q12996
YREPSLHDVGETVPK	FGF14	206	Q92915
SHSGPYELRIEVQPK	NFATC1	421	O95644
LFPLPGRDHKYAVEI	MEGF8	791	Q7Z7M0
YAIPPEHGKRLERLA	KDM4C	211	Q9H3R0
IIKHETLPYGRPRVL	ENPP1	651	P22413
VLNRYVEGKHPPEKL	HSPA12A	541	O43301
DPPDDPKEYIHRVGR	DDX18	501	Q9NVP1
VVYIGSAGKPHERVE	DDX23	626	Q9BUQ8
VEIADTVPKYLRPHL	IPO5	241	O00410
PDIVVQPGHIRLYVV	MPZL1	141	O95297
PHYRVEPSLEGALTK	ERMN	41	Q8TAM6
IIADYEVHPNRRPKI	MMACHC	101	Q9Y4U1
PDKRLADKYPVVHIG	PLOD2	146	O00469
GDDDKEYLVRVHVPP	HMCN1	3606	Q96RW7
VGVVDVPYLVLEPTH	MORC2	411	Q9Y6X9
KGHPGYIAVDEVRVL	PTPRT	171	O14522
STREIQGIEKHPYPE	PPP1R3A	956	Q16821
KRTVIIPPHLGYGEA	FKBP9	441	O95302
LHADRGIITSPKYPE	CUBN	2096	O60494
VIPLPHIYGARIKGV	FAM189A2	171	Q15884
EQVPERGLVSVPKYH	DNAH1	476	Q9P2D7
GEKSYRERVPGAPHI	DNAH1	2391	Q9P2D7
ERPLPAIRKHYGEAV	CEP104	381	O60308
YKDGEVDHPIIQPRS	CACNA1C	1096	Q13936
HYGVITLPPNLTERK	DOCK5	1636	Q9H7D0
PKEHRIGIPEFKYVA	CPM	66	P14384
VVPGYGHAVLRKTDP	CS	341	O75390
EHKPLVLRPVYIGTV	CMYA5	211	Q8N3K9
VDGGIPVKHSLIPVY	FAT3	2681	Q8TDW7
IIYGSEQIPKPHVIV	GALNTL5	56	Q7Z4T8
PRHIPGVVEVTLSYK	EBF1	316	Q9UH73
VHYARPIIILGPTKD	DLG4	531	P78352
KLGERDDTIPPEYRH	CAST	606	P20810
DEDRPEVHKPISGRY	LY9	546	Q9HBG7
VKLDLEGVVFPYHPR	HAPLN4	156	Q86UW8
EATVPQYHAVKIPRE	ITGA7	1116	Q13683
TDPVAYRLEPLILKH	DDHD1	661	Q8NEL9
KDVVRYLLDHAPPEI	DGKZ	836	Q13574
LLEKGVYVHTVRPDG	GRIP2	961	Q9C0E4
HKYPPEERGDLLVFL	DHX34	371	Q14147
VVKIPSRVHGSLEPF	PWWP2B	266	Q6NUJ5
DEQHGKKVPTVSRPY	SEC22B	96	O75396
PYLGDVAVVVHPGKK	DPYSL5	491	Q9BPU6
IPLGAHQRPEETYKK	NYNRIN	1551	Q9P2P1
LPAKYVIHTVGPIAR	MACROD2	136	A1Z1Q3
RPLIKVEEGRAPSYH	NR4A3	81	Q92570
FREPPAVTVHYIADK	NRAC	71	Q8N912
LEEGHYVIGPKIDIP	GAREM2	66	Q75VX8
YPKRLEKEVGTPHGI	HPX	341	P02790
AIDHYVTPVKAGRLV	MRPL16	146	Q9NX20
YHRAIKVTVDGPREP	RUNX3	166	Q13761
IASHFVPPRVIIKEG	RRN3	151	Q9NYV6
GIRHSIYPGEEAIKP	DROSHA	546	Q9NRR4
VEPIYTFRAHKGPVL	STRN	506	O43815
VFPHYIEKPLGRVGV	TRIM43	391	Q96BQ3
PVDKIHPSLKEVLGY	SOS2	106	Q07890
PKIPLHVRYGEDVRQ	TCAF2	201	A6NFQ2
AYETAKVHPREVAKP	PKDREJ	1486	Q9NTG1
PSAKEVFKERIGYPH	NBEAL2	396	Q6ZNJ1
KIAPRYSAPVIHVLD	MTR	871	Q99707
EGYRGKKRQEAPPHI	MYH3	141	P11055
EKYIPPHVRQAEETV	NOM1	336	Q5C9Z4
VAYKLDGEIIPHIPA	ADSS2	376	P30520
TLPKHISEVPGVDDY	IMPG2	701	Q9BZV3
GDVYIPREPHTKAPR	SRSF8	41	Q9BRL6
QHPSKIPVIIERYKG	MAP1LC3A	26	Q9H492
IGTAYEGHVRIPKPA	CDC42BPA	1081	Q5VT25
GVPLYAVVKEHIRTE	PRXL2A	106	Q9BRX8
EKRVTVIKAPHYPGI	SORBS2	61	O94875
QRTEHPVISYKEIGP	SEMA5A	31	Q13591
GIPYHSEVPVSLKEA	SPTBN1	2246	Q01082
REIHCPGYVLPVKVV	CILP2	446	Q8IUL8
RYHDIEPGAVVKGTV	PDCD11	446	Q14690
RHSLIGPDIKITYVP	MPDZ	1076	O75970
GPDIKITYVPAEHLE	MPDZ	1081	O75970
EYERRSLVHEVGKPP	SPEN	1201	Q96T58
ELKIRPHGYSREPVL	TNN	1271	Q9UQP3
PDVKYGKRIHVLPID	VCP	106	P55072
HPAVLPIYEELKDRS	SLC38A2	306	Q96QD8
KVHEPVRIAYDRPRG	SUGP2	976	Q8IX01
AKPYEIVVDLTHTGP	NF1	1636	P21359
SHKYVPRAILVDLEP	TUBB3	56	Q13509
SGKAEPRLPDRVYIH	TBX6	161	O95947
LPKLSPGKHDIYVEV	PKHD1L1	1296	Q86WI1
IASHFVPPRVIIKEG	RRN3P2	151	A6NIE6
DGRGKPLPEYHVRIA	PRKDC	3706	P78527
EAPAVPALRLGIYVH	TPCN1	126	Q9ULQ1
VPHIYAIGDVVEGRP	TXNRD2	351	Q9NNW7
GEPELHYLRLPKDIS	UCKL1	431	Q9NWZ5
VFPHYIEKPLGRVGV	TRIM43B	391	A6NCK2
AGIYLHVNEKIPRPT	ZNF18	271	P17022
SVTVDPKYHPKIIGR	HDLBP	1056	Q00341
HEIESLYTKLGKVPP	WNK1	2096	Q9H4A3
LKIHPAEPRDSAVYL	TRBV17	96	A0A087X0K7
DVPPHLKRLGVLLDY	MID2	646	Q9UJV3
GYHRVVEIPEGATKI	THSD4	426	Q6ZMP0
RRESLVHVPGYDPKD	SLC5A12	591	Q1EHB4
SEYIEPAKRAHVVPP	VIRMA	1606	Q69YN4
YIPRILFLDPSGKVH	TXNDC12	111	O95881
VRIHTGEKPYVCTVP	ZNF76	306	P36508
YRLPHPVKEENVAGR	ZNF541	806	Q9H0D2
GSRKYPPHLVEVEAI	MYO7A	1881	Q13402